Considering RSPOs in ovarian cancer, in silico analysis suggested relatively high RSPO1 mRNA expression in ovarian cancer, and another study reported high expression of RSPO1 and RSPO3 in ovarian tumor xenograft material [116, 122]. This evidence concerns the gene RSPO3 and ovarian neoplasm.